{"schema_version":"alpha-profile-public-v1","slug":"barry-flannelly-pharm-d","canonical_url":"https://registry.alpha.ac/people/barry-flannelly-pharm-d","as_of":"2026-09-21T22:36:19.148258+00:00","published_at":"2026-09-02T02:37:24.7337+00:00","last_reviewed_at":"2026-05-16T02:53:16.858+00:00","identity":{"display_name":"Barry Flannelly, Pharm.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Protara Therapeutics, Inc.","company_slug":"protara-therapeutics-inc","exchange":"NASDAQ","ticker":"TARA","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-28T23:48:01.761+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=barry-flannelly-pharm-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=barry-flannelly-pharm-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Barry Flannelly has served as Executive Vice President and General Manager, North America at Incyte Corporation since June 2015. He previously held senior commercial and strategic roles at Nektar Therapeutics, Onyx Pharmaceuticals, and other biopharmaceutical companies. He holds a B.S. in Pharmacy, MBA, and Pharm.D. from various institutions."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Protara Therapeutics, Inc.","organizationId":"protara-therapeutics-inc","title":"Director","period":"2020-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Protara Therapeutics, Inc.","company_slug":"protara-therapeutics-inc","exchange":"NASDAQ","ticker":"TARA","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-28T23:48:01.761+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Barry Flannelly, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:53:17.040407+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T02:53:16.932429+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Barry Flannelly, Pharm.D. currently serves as Director at Protara Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:53:17.004148+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T02:53:16.932429+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation"],"claim_text":"Barry Flannelly, Pharm.D. serves on Compensation.","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:53:17.023319+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T02:53:16.932429+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Incyte Corporation","claim_text":"Barry Flannelly, Pharm.D. is linked to Incyte Corporation as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:53:17.138532+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T02:53:16.932429+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Executive Vice President and General Manager, North America","claim_text":"Barry Flannelly, Pharm.D. is also listed as Executive Vice President and General Manager, North America.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:53:17.122545+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T02:53:16.932429+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Barry Flannelly, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:53:17.074036+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T02:53:16.932429+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Barry Flannelly, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:53:17.05722+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TARA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-16T02:53:16.932429+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:barry-flannelly-pharm-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2020-01-01 · current","organization":"Protara Therapeutics, Inc.","organization_id":"protara-therapeutics-inc"},"claim_text":"Director at Protara Therapeutics, Inc. (2020-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/barry-flannelly-pharm-d#profile","url":"https://registry.alpha.ac/people/barry-flannelly-pharm-d","dateModified":"2026-05-16T02:53:16.858+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/barry-flannelly-pharm-d#person","name":"Barry Flannelly, Pharm.D.","url":"https://registry.alpha.ac/people/barry-flannelly-pharm-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Protara Therapeutics, Inc.","tickerSymbol":"NASDAQ: TARA"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","memberOf":{"@type":"Organization","name":"Protara Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/protara-therapeutics-inc","tickerSymbol":"NASDAQ: TARA"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","name":"TARA DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/barry-flannelly-pharm-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T02:53:16.858+00:00","observed_at":"2026-09-21T22:36:19.148258+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"barry-flannelly-pharm-d","canonical_url":"https://registry.alpha.ac/people/barry-flannelly-pharm-d"},"publication":{"published_at":"2026-09-02T02:37:24.7337+00:00","last_reviewed_at":"2026-05-16T02:53:16.858+00:00","as_of":"2026-09-21T22:36:19.148258+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/barry-flannelly-pharm-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/barry-flannelly-pharm-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/barry-flannelly-pharm-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}